Relationship Between Glomerular Filtration Rate and 24-Hour Urine Composition in Patients With Nephrolithiasis


      To examine the relationship between GFR and 24-hour urine composition in patients with nephrolithiasis to understand how renal function may affect stone risk. Alterations in glomerular filtration rate (GFR) are associated with a number of physiological changes.


      A retrospective, institutional review board–approved review of patients from 2 metabolic stone clinics was performed. One-way analysis of variance and multivariate linear regression models were used to evaluate the relationship between GFR quintile and 24-hour urine composition.


      A total of 403 patients (241 male, 162 female) with a mean age of 52.6 ± 14.2 years were included in the study. On univariate analysis, decreasing GFR by quintile was associated with significant reductions in urine calcium, citrate, supersaturation of calcium oxalate, and supersaturation of calcium phosphate (P < .05 for each). In multivariate linear regression models, decreasing GFR by quintile was associated with significant decreases in urine calcium (β = −11.2, 95% CI = −18.3 to 4.01), urine citrate (β = −32.4, 95% CI = −54.1 to 10.8), oxalate (β = −1.83, 95% CI = −2.85 to 0.81), supersaturation of calcium oxalate (β = −0.58, 95% CI = 0.84 to 0.33) and supersaturation of calcium phosphate (β = −0.09, 95% CI = 0.17 to 0.02), as well as an increase in urine magnesium (β = 3.40, 95% CI = 0.7 to 6.1).


      Reduction in GFR is associated with decreased urine calcium, oxalate, and citrate, and increased urine magnesium. These findings have implications for treatment of patients with stone disease and impaired renal function.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Coresh J.
        • Selvin E.
        • Stevens L.A.
        • et al.
        Prevalence of chronic kidney disease in the United States.
        JAMA. 2007; 298: 2038-2047
        • Snyder J.J.
        • Foley R.N.
        • Collins A.J.
        Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
        Am J Kidney Dis. 2009; 53: 218-228
        • Stamatelou K.K.
        • Francis M.E.
        • Jones C.A.
        • et al.
        Time trends in reported prevalence of kidney stones in the United States: 1976-1994.
        Kidney Int. 2003; 63: 1817-1823
        • Jungers P.
        • Joly D.
        • Barbey F.
        • et al.
        ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.
        Am J Kidney Dis. 2004; 44: 799-805
        • Rule A.D.
        • Bergstralh E.J.
        • Melton 3rd, L.J.
        • et al.
        Kidney stones and the risk for chronic kidney disease.
        Clin J Am Soc Nephrol. 2009; 4: 804-811
        • Saucier N.A.
        • Sinha M.K.
        • Liang K.V.
        • et al.
        Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota.
        Am J Kidney Dis. 2010; 55: 61-68
        • Vupputuri S.
        • Soucie J.M.
        • McClellan W.
        • et al.
        History of kidney stones as a possible risk factor for chronic kidney disease.
        Ann Epidemiol. 2004; 14: 222-228
        • Tseng T.Y.
        • Stoller M.L.
        Medical and medical/urologic approaches in acute and chronic urologic stone disease.
        Med Clin North Am. 2011; 95: 169-177
        • Taylor E.N.
        • Curhan G.C.
        Differences in 24-hour urine composition between black and white women.
        J Am Soc Nephrol. 2007; 18: 654-659
        • Oreopoulos D.G.
        • Walker D.
        • Akriotis D.J.
        • et al.
        Excretion of inhibitors of calcification in urine part II.
        Can Med Assoc J. 1975; 112: 832-834
        • Worcester E.
        • Parks J.H.
        • Josephson M.A.
        • et al.
        Causes and consequences of kidney loss in patients with nephrolithiasis.
        Kidney Int. 2003; 64: 2204-2213
        • Castle S.M.
        • Cooperberg M.R.
        • Sadetsky N.
        • et al.
        Adequacy of a single 24-hour urine collection for metabolic evaluation of recurrent nephrolithiasis.
        J Urol. 2010; 184: 579-583
        • Bes-Rastrollo M.
        • Sabate J.
        • Jaceldo-Siegl K.
        • et al.
        Validation of self-reported anthropometrics in the Adventist Health Study 2.
        BMC Public Health. 2011; 11: 213-223